ESBER HENRY JEMIL 4
4 · INNOVUS PHARMACEUTICALS, INC. · Filed Jul 3, 2019
Insider Transaction Report
Form 4
ESBER HENRY JEMIL
Director
Transactions
- Award
Restricted Stock Units
2019-07-01$1.52/sh+5,922$9,001→ 34,656 totalFrom: 2019-07-01Exp: 2029-07-01→ Common Stock (5,922 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock.
- [F2]The Reporting Person was granted a Restricted Stock Unit on July 1, 2019 of 5,922 shares, which were fully vested on the date of the grant. The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the second quarter of 2019 and was valued on June 28, 2019 in accordance with the approved compensation plan for the non-employee members of the Board of Directors.
- [F3]These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan.